This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Yelena Lyubarskaya, PhD
Analytical Strategy Lead, Technical Development at Moderna


Yelena Lyubarskaya is the Analytical Strategy Lead in Technical Development department at Moderna. She obtained her PhD in Bioanalytical Chemistry at Northeastern University at Boston, MA, USA. After completing her doctoral degree, Yelena worked in a number of biotechnology and pharmaceutical companies over the years from startup biotech to global pharma corporations, with the longest tenure at Biogen and Sanofi. Throughout her career, Yelena held various leadership positions in Analytical Development, Technical Development and CMC strategy encompassing a wide range of therapeutic modalities from small molecules to complex and diverse biologics. In her current role at Moderna, Yelena and her team are focused on developing and streamlining analytical and process control strategy for mRNA-LNP based vaccines and therapeutics.

Agenda Sessions

  • Chairperson's Remarks

  • Development of mRNA-LNP Therapeutics